In May, we added 116 citations in DIDB, including 55 in vitro (with 29 articles published in May 2026) and 61 in vivo articles (with 41 articles published in May 2026).
4 drugs approved by the FDA from Feb to April in 2026, including doravirine and islatravir (IDVYNSO), linerixibat (LYNAVOY), navepegritide (YUVIWEL), and orforglipron (FOUNDAYO), were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.